Ann M. Gillenwater, MD
Department of Head and Neck Surgery, Division of Surgery
Present Title & Affiliation
Primary Appointment
Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Detection and treatment of early oral cancer and precancer
Merkel Cell Carcinoma
Developing optical imaging for oral cancer detection
Education & Training
Degree-Granting Education
| 1987 | University of Virginia, Charlottesville, VA, USA, MD, Medicine |
| 1983 | Brown University, Providence, RI, USA, BA, Russian Studies |
Postgraduate Training
| 1993-1994 | Clinical Fellowship, Dept. of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1992-1993 | Research Fellowship, Dept. of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1989-1992 | Otolaryngology Resident, Dept. of Otolaryngology/Head & Neck Surgery, UT Health Science Center at Houston, Houston, TX |
| 1987-1989 | Surgical Internship, Dept. of General Surgery, UT Health Science Center At Houston, Houston, TX |
Board Certifications
| 1993 | American Board of Otolaryngology |
Experience & Service
Administrative Appointments/Responsibilities
Director, Oral Cancer Prevention Center, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - Present
Honors & Awards
| 2002 | Honor Award, American Academy of Otolaryngology-Head & Neck Surgery |
| 2001 | UT MD Anderson Educator of the Month Award, UT MD Anderson Cancer Center |
| 1996 | Triological Society Research Training Award |
| 1983 | Magna Cum Laude, Brown University |
| 1982 | Phi Beta Kappa, Brown University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS. Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy. Head Neck 39(4):633-638, 2017. e-Pub 2016. PMID: 28006086.
- Kawedia JD, Zhang YP, Myers AL, Richards-Kortum RR, Kramer MA, Gillenwater AM, Culotta KS. Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer. J Oncol Pharm Pract 22(1):21-5, 2016. e-Pub 2014. PMID: 25113309.
- William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol 2(2):1-8, 2016. e-Pub 2015. PMID: 26540028.
- Lukianova-Hleb EY, Kim YS, Belatsarkouski I, Gillenwater AM, O'Neill BE, Lapotko DO. Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles. Nat Nanotechnol. e-Pub 2016. PMID: 26878142.
- Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS. Depression and Oropharynx Cancer Outcome. Psychosom Med 78(1):38-48, 2016. PMID: 26632757.
- Ishijima A, Schwarz RA, Shin D, Mondrik S, Vigneswaran N, Gillenwater AM, Anandasabapathy S, Richards-Kortum R. Automated frame selection process for high-resolution microendoscopy. J Biomed Opt 20(4):46014, 2015. PMID: 25919426.
- Floriano P, Abram T, Taylor L, Le C, Talavera H, Nguyen M, Raja R, Gillenwater A, McDevitt J, Vigneswaran N. Programmable Bio-Nano-Chip based Cytologic Testing of Oral Potentially Malignant Disorders in Fanconi Anemia. Oral Dis. e-Pub 2015. PMID: 25662766.
- Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SF, Phan J, Morrison WH. Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. Head Neck. e-Pub 2015. PMID: 25645649.
- Gillenwater AM, Zhong M, Lotan R. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcionoma cells. Mol Cancer Ther 6(11):2967-2975, 2007. PMID: 18025281.
Other Articles
- Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK Proliferative verrucous leukoplakia (PVL): Recognition and differentiation from conventional leukoplakia and mimics!. Head Neck 36(11):1662-8, 2014. PMID: 24115154.
Book Chapters
- Schwarz RA, Richards-Kortum RR, Gillenwater AM. Fluorescence and Reflectance Spectroscopy for Detection of Oral Dysplasia and Cancer. In: Biomedical Optics in Otorhinolaryngology Head and Neck Surgery. Springer: New York, 431-450, 2016.
Patient Reviews
CV information above last modified November 02, 2023